Hypothesis

57 Matching Annotations

Last 7 days
www.sciencedirect.com:5037 www.sciencedirect.com:5037

An innovative engineered IL-10 monomer strengthens T cell-mediated anti-tumor responses through anti-PD-1 cis-delivery

1
1. scibot 17 Dec 2025
  
  in Public
  
  ATCCCRL-2755
  
  DOI: 10.1016/j.xcrm.2025.102515
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @areedewitt04
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com:5037/science/article/pii/S2666379125005889
Nov 2025
www.sciencedirect.com www.sciencedirect.com

Non-orthosteric inhibition of enolase 1 impedes growth of triple-negative breast cancer

1
1. scibot 13 Nov 2025
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1016/j.xcrm.2025.102451
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379125005245
www.sciencedirect.com www.sciencedirect.com

StealTHY: An immunogen-free CRISPR platform to expose concealed metastasis regulators in immunocompetent models

1
1. scibot 08 Nov 2025
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1016/j.cell.2025.10.007
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0092867425011365
Oct 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Overexpression of RUNX2 promotes breast cancer multi-organ metastasis through stabilizing c-Myc

1
1. scibot 17 Oct 2025
  
  in Public
  
  RRID: CVCL_1923
  
  DOI: 10.1038/s41419-025-08018-9
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12501288/
Sep 2025
www.sciencedirect.com www.sciencedirect.com

Modulation of fibronectin extracellular matrix enhances anti-tumor efficacy of immune checkpoint blockade

1
1. scibot 09 Sep 2025
  
  in Public
  
  CVCL_1923
  
  DOI: 10.1016/j.xcrm.2025.102322
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379125003957
Aug 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

T cells Instruct Immune Checkpoint Inhibitor Therapy Resistance in Tumors Responsive to IL-1 and TNFα Inflammation

1
1. scibot 05 Aug 2025
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2326-6066.CIR-24-0416
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC11790381/
Jul 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin

1
1. scibot 04 Jul 2025
  
  in Public
  
  CVCL_1923
  
  DOI: 10.1158/0008-5472.CAN-24-0749
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @sonofthor
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12214879/
Apr 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Trabectedin Enhances the Antitumor Effects of IL-12 in Triple-Negative Breast Cancer

1
1. scibot 04 Apr 2025
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2326-6066.CIR-24-0775
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC11962391/
52.53.155.43 52.53.155.43

PDF-html.html

1
1. scibot 03 Apr 2025
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/0008-5472.can-24-0749/3563696/can-24-0749.
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @sjvitug
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

52.53.155.43/73f4a278983fd3a9b93fed6443158024ffc69ddc/PDF-html.html
www.sciencedirect.com www.sciencedirect.com

Soluble CTLA-4 regulates immune homeostasis and promotes resolution of inflammation by suppressing type 1 but allowing type 2 immunity

1
1. scibot 01 Apr 2025
  
  in Public
  
  ATCCCat#CRL-2755
  
  DOI: 10.1016/j.immuni.2025.03.004
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @areedewitt04
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1074761325001232
Mar 2025
www.sciencedirect.com www.sciencedirect.com

Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative breast cancer

1
1. scibot 29 Mar 2025
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1016/j.immuni.2025.03.002
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1074761325000962
Feb 2025
www.sciencedirect.com www.sciencedirect.com

MIF-ACKR3 causes irreversible fat loss by impairing adipogenesis in cancer cachexia

1
1. scibot 28 Feb 2025
  
  in Public
  
  ATCCCat# CRL-2755
  
  DOI: 10.1016/j.cmet.2025.01.018
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @areedewitt04
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S155041312500018X
www.sciencedirect.com www.sciencedirect.com

Potentiating anti-tumor immunity by re-engaging immune synapse molecules

1
1. scibot 25 Feb 2025
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1016/j.xcrm.2025.101975
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379125000485
aacrjournals.org aacrjournals.org

Triple-negative breast cancer-derived extracellular vesicles promote a hepatic pre-metastatic niche via a cascade of microenvironment remodeling

1
1. scibot 13 Feb 2025
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/1541-7786.MCR-22-0673
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

aacrjournals.org/mcr/article/21/7/726/727474/Triple-Negative-Breast-Cancer-Derived
Jan 2025
aacrjournals.org aacrjournals.org

High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNγ Signaling Pathway Defects

1
1. scibot 31 Jan 2025
  
  in Public
  
  CRL-2755
  
  DOI: 10.1158/2326-6066.CIR-22-0815
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @areedewitt04
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

aacrjournals.org/cancerimmunolres/article/11/7/895/727496/High-Expression-of-MHC-Class-I-Overcomes-Cancer
www.sciencedirect.com www.sciencedirect.com

Dual ferroptosis induction in N2-TANs and TNBC cells via FTH1 targeting: A therapeutic strategy for triple-negative breast cancer

1
1. scibot 14 Jan 2025
  
  in Public
  
  ATCCCRL-2755
  
  DOI: 10.1016/j.xcrm.2024.101915
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @areedewitt04
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379124006864
52.53.155.43 52.53.155.43

PDF-html.html

1
1. scibot 10 Jan 2025
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2326-6066.cir-24-0775
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

52.53.155.43/009f00f9e3d39df3c2a4236499ac454ff01f615a/PDF-html.html
www.sciencedirect.com www.sciencedirect.com

Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1

1
1. scibot 09 Jan 2025
  
  in Public
  
  ATCCCat# CRL-2755
  
  DOI: 10.1016/j.ccell.2024.11.008
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @areedewitt04
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610824004434
Dec 2024
www.sciencedirect.com www.sciencedirect.com

Arming Oncolytic M1 Virus with Gasdermin E Enhances Antitumor Efficacy in Breast Cancer

1
1. scibot 19 Dec 2024
  
  in Public
  
  ATCCCRL-2755
  
  DOI: 10.1016/j.isci.2024.111148
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @areedewitt04
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2589004224023733
www.sciencedirect.com www.sciencedirect.com

A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor

1
1. scibot 10 Dec 2024
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1016/j.cell.2024.11.009
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0092867424013266
Sep 2024
www.sciencedirect.com www.sciencedirect.com

FABP4-mediated lipid metabolism promotes TNBC progression and breast cancer stem cell activity

1
1. scibot 25 Sep 2024
  
  in Public
  
  CRL-2755
  
  DOI: 10.1016/j.canlet.2024.217271
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @vtello
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0304383524006669
www.sciencedirect.com www.sciencedirect.com

Small-molecule GSDMD agonism in tumors stimulates antitumor immunity without toxicity

1
1. scibot 10 Sep 2024
  
  in Public
  
  CRL-2755
  
  DOI: 10.1016/j.cell.2024.08.007
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @vtello
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0092867424008985
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination

1
1. scibot 05 Sep 2024
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2326-6066.CIR-23-0289
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC11369622/
Aug 2024
www.sciencedirect.com www.sciencedirect.com

Uncovering therapeutic targets for macrophage-mediated T cell suppression and PD-L1 therapy sensitization

1
1. scibot 27 Aug 2024
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1016/j.xcrm.2024.101698
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @vtello
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379124004191
Jul 2024
www.sciencedirect.com www.sciencedirect.com

Loss of ZNF408 attenuates STING-mediated immune surveillance in breast carcinogenesis

1
1. scibot 24 Jul 2024
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1016/j.isci.2024.110276
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2589004224015013
May 2024
www.sciencedirect.com www.sciencedirect.com

A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death

1
1. scibot 24 May 2024
  
  in Public
  
  CRL-2755
  
  DOI: 10.1016/j.immuni.2024.04.025
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @abever99
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1074761324002309
www.sciencedirect.com www.sciencedirect.com

Inhibition of protein translational machinery in triple-negative breast cancer as a promising therapeutic strategy

1
1. scibot 10 May 2024
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1016/j.xcrm.2024.101552
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379124002441
Apr 2024
www.sciencedirect.com www.sciencedirect.com

IGSF8 is an innate immune checkpoint and cancer immunotherapy target

1
1. scibot 24 Apr 2024
  
  in Public
  
  Cat# CRL-2755
  
  DOI: 10.1016/j.cell.2024.03.039
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @abever99
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0092867424003556
Mar 2024
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Generation of murine tumor models refractory to αPD-1/-L1 therapies due to defects in antigen processing/presentation or IFNγ signaling using CRISPR/Cas9

1
1. scibot 06 Mar 2024
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1371/journal.pone.0287733
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC10906908/
Feb 2024
www.sciencedirect.com www.sciencedirect.com

Downregulation of IRF8 in alveolar macrophages by G-CSF promotes metastatic tumor progression

1
1. scibot 29 Feb 2024
  
  in Public
  
  ATCCCat#CRL-2755
  
  DOI: 10.1016/j.isci.2024.109187
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @abever99
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2589004224004085
www.sciencedirect.com www.sciencedirect.com

Preclinical characterization and phase 1 results of ADG106 in patients with advanced solid tumors and non-Hodgkin’s lymphoma

1
1. scibot 08 Feb 2024
  
  in Public
  
  ATCCCRL-2755
  
  DOI: 10.1016/j.xcrm.2024.101414
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @abever99
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379124000375
Jan 2024
transmedcomms.biomedcentral.com transmedcomms.biomedcentral.com

iMN041 is an immunotherapeutic and an effective treatment in mouse xenograft models of pancreatic cancer, renal cancer and triple negative breast cancer

1
1. scibot 25 Jan 2024
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1186/s41231-024-00161-3
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

transmedcomms.biomedcentral.com/articles/10.1186/s41231-024-00161-3
www.sciencedirect.com www.sciencedirect.com

Interferon-stimulated neutrophils as a predictor of immunotherapy response

1
1. scibot 09 Jan 2024
  
  in Public
  
  CRL-2755
  
  DOI: 10.1016/j.ccell.2023.12.005
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @abever99
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610823004336
Nov 2023
www.sciencedirect.com www.sciencedirect.com

Anti-tumor effect of PD-L1-targeting antagonistic aptamer-ASO delivery system with dual inhibitory function in immunotherapy

1
1. scibot 17 Nov 2023
  
  in Public
  
  RRID: CVCL_1923
  
  DOI: 10.1016/j.chembiol.2023.10.010
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @jmitrevska
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2451945623003719
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer

2
1. scibot 03 Nov 2023
  
  in Public
  
  ATTC, CRL-2755
  
  DOI: 10.1158/1535-7163.MCT-23-0303
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
2. scibot 03 Nov 2023
  
  in Public
  
  ATCC (CRL-2755)
  
  DOI: 10.1158/1535-7163.MCT-23-0303
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC10618734/
Oct 2023
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Functional inhibition of the RNA‐binding protein HuR sensitizes triple‐negative breast cancer to chemotherapy

1
1. scibot 07 Oct 2023
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1002/1878-0261.13478
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC10552894/
Sep 2023
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

S-531011, a Novel Anti-Human CCR8 Antibody, Induces Potent Antitumor Responses through Depletion of Tumor-Infiltrating CCR8-Expressing Regulatory T Cells

1
1. scibot 07 Sep 2023
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/1535-7163.MCT-22-0570
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC10477828/
Aug 2023
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Activating Inducible T cell Co-stimulator (ICOS) yields anti-tumor activity alone and in combination with anti-PD-1 checkpoint blockade

3
1. scibot 26 Aug 2023
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2767-9764.CRC-22-0293
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
2. scibot 26 Aug 2023
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2767-9764.CRC-22-0293
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
3. scibot 26 Aug 2023
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2767-9764.CRC-22-0293
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC10430783/
52.53.155.43 52.53.155.43

crc-22-0293-html.html

2
1. scibot 11 Aug 2023
  
  in Public
  
  CVCL_1923
  
  DOI: 10.1158/2767-9764.CRC-22-0293
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
2. scibot 11 Aug 2023
  
  in Public
  
  CVCL_1923
  
  DOI: 10.1158/2767-9764.CRC-22-0293
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

52.53.155.43/4f107a6ec2874295e908f0e6a1a5e9653abe6492/crc-22-0293-html.html
dx.doi.org dx.doi.org

NL-201 upregulates MHC-I expression and intratumoral TCR diversity, and demonstrates robust antitumor activity as monotherapy and in combination with PD-1 blockade

1
1. scibot 09 Aug 2023
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2326-6066.CIR-22-0304
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

dx.doi.org/10.1158/2326-6066.CIR-22-0304
Jul 2023
52.53.155.43 52.53.155.43

mcr-22-0673-html.html

1
1. scibot 02 Jul 2023
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/1541-7786.MCR-22-0673
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

52.53.155.43/5cc780ea6bc578a6755d505f34922fb0e77b2333/mcr-22-0673-html.html
Feb 2023
aacrjournals.org aacrjournals.org

Bone metastasis initiation is coupled with bone remodeling through osteogenic differentiation of NG2+ cells

1
1. scibot 18 Feb 2023
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2159-8290.CD-22-0220
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

aacrjournals.org/cancerdiscovery/article/13/2/474/716294/Bone-Metastasis-Initiation-Is-Coupled-with-Bone
Jan 2023
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Vitamin E Enhances Cancer Immunotherapy by Reinvigorating Dendritic Cells via Targeting Checkpoint SHP1

1
1. scibot 07 Jan 2023
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2159-8290.CD-21-0900
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC9262841/
Dec 2022
52.53.155.43 52.53.155.43

cd-22-0220-html.html

1
1. scibot 03 Dec 2022
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2159-8290.CD-22-0220
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

52.53.155.43/b725a3c3e409b5ecfb6e439733821b69db1577f5/cd-22-0220-html.html
Jun 2022
52.53.155.43 52.53.155.43

cd-21-0900-html.html

3
1. scibot 30 Jun 2022
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2159-8290.cd-21-0900
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
2. scibot 25 Jun 2022
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2159-8290.cd-21-0900
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
3. scibot 22 Jun 2022
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2159-8290.cd-21-0900
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

52.53.155.43/d5bf83c5c1736aa8a79b5cf8b82689398b415edf/cd-21-0900 (2)-html.html
aacrjournals.org aacrjournals.org

Phosphorylation and stabilization of PD-L1 by CK2 suppresses dendritic cell function

1
1. scibot 14 Jun 2022
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/0008-5472.CAN-21-2300
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

aacrjournals.org/cancerres/article/82/11/2185/699105/Phosphorylation-and-Stabilization-of-PD-L1-by-CK2
Apr 2022
www.sciencedirect.com www.sciencedirect.com

Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche

1
1. scibot 21 Apr 2022
  
  in Public
  
  ATCCCat#CRL-2755
  
  DOI: 10.1016/j.cell.2022.03.033
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @sophiastull
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0092867422003439
Nov 2021
www.sciencedirect.com www.sciencedirect.com

The allergy mediator histamine confers resistanceto immunotherapy in cancer patients via activationof the macrophage histamine receptor H1

1
1. scibot 25 Nov 2021
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1016/j.ccell.2021.11.002
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610821006024
Sep 2021
www.sciencedirect.com www.sciencedirect.com

In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target

1
1. scibot 28 Sep 2021
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1016/j.cell.2021.09.006
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0092867421010539
Jul 2021
www.nature.com www.nature.com

Selective therapeutic strategy for p53-deficient cancer by targeting dysregulation in DNA repair

1
1. scibot 21 Jul 2021
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1038/s42003-021-02370-0
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

nature.com/articles/s42003-021-02370-0
Sep 2020
cancerimmunolres.aacrjournals.org cancerimmunolres.aacrjournals.org

Anti-VEGF Treatment Enhances CD8+ T-Cell Antitumor Activity by Amplifying Hypoxia

1
1. scibot 05 Sep 2020
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2326-6066.CIR-19-0360
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @Naa003
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRIDCUR:Validated RRID:CVCL_1923
Visit annotations in context

Tags

RRIDCUR:Validated

RRID:CVCL_1923

Annotators

scibot

URL

cancerimmunolres.aacrjournals.org/content/8/6/806